Este estudo objetivou analisar o controle glicêmico de mulheres gaúchas diagnosticadas com DM2 que não utilizavam insulina e faziam uso de antidepressivos e/ou ansiolíticos durante a pandemia de Covid-19. Para isso, realizou-se um estudo transversal de caráter descritivo composto por dois grupos: grupo estudo (uso de psicofármacos) e grupo controle (sem uso de psicofármacos). Além disso, a coleta de dados ocorreu em dois momentos, denominados período pandêmico e período de estabilização da pandemia. A amostra foi composta por 47 indivíduos do sexo feminino. A Fluoxetina foi o fármaco mais utilizado, seguido do Diazepam e da Amitriptilina. Foi encontrada redução significativa da hemoglobina glicada e melhor controle glicêmico no grupo estudo em relação ao grupo controle. Esses dados indicam que o uso dos antidepressivos e ansiolíticos analisados pode estar associado a um melhor controle glicêmico em mulheres com DM2 que necessitam dessas medicações.

Purpose: In Brazil, diabetes mellitus represents 8.8% of the population between 20 and 79 years of age. Disease control is associated with adherence to healthy lifestyle habits, promoting adequate glycemic control monitored by glycated hemoglobin. Therefore, the objective of this study was to analyze the glycemic control of people with Type 2 Diabetes Mellitus during the COVID-19 pandemic. Material and methods: The present research was a cross-sectional descriptive study. Through glycated hemoglobin, it evaluated the glycemic control of people with Type 2 Diabetes Mellitus during two periods of the pandemic. The first period was from March 2020 to June 2021, and the second was from July 2021 to February 2022. Results: There was a significant reduction in glycated hemoglobin from 8.4% in the pandemic period to 8% (p=0.035) in the stabilization period. This reduction was most evident in the group with glycated hemoglobin ≥7 in the pandemic period (p=0.007) and among women (p=0.008). The group who reduced their consumption of ultra-processed foods lowered a glycated hemoglobin from 8.3% to 7.6% (p=0.010), and those who used antidepressants decreased it from 7.6% to 7% (p=0.032). Conclusion: A reduction in the glycated hemoglobin of people with Type 2 Diabetes Mellitus occurred during the COVID-19 pandemic.